November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) approval to initiate the company’s ELITE-BTK pivotal trial of Magnitude, its ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

November 11, 2024—iVascular announced the initiation of OPAL, a first-in-human study of Amber, the company’s embolic liquid ...

The codes describing endovascular procedures for lower extremity revascularization have been completely revised, effective January 1, 2011. This was done in response to requests to continue bundling ...

The concept of angiosome-directed therapy (ADT) has gained significant relevance. An angiosome is a three-dimensional anatomic unit of tissue (consisting of skin, subcutaneous tissue, fascia, muscle, ...

CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim p ...

Endovascular revascularization of patients with PVD has evolved dramatically, and we now have a better understanding of the atherosclerotic process. Traditionally, therapy has been delivered through ...

LeMaitre Vascular, Inc. Glow 'N Tell 55-cm Tape 55 Centimeter markings on flexible radiopaque ruler LeMaitre Vascular, Inc. Glow 'N Tell Tape 30 Centimeter markings on flexible radiopaque ruler ...

Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...

This article is a companion to “Coding for Lower Extremity Revascularization in 2011,” which was published in Endovascular Today'sMay 2011 issue. In January 2011, 16 new codes were introduced, ...

A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with intermediate-risk ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...